Measurement and clinical significance of circulating PAPP-A in ACS patients

Clinica Chimica Acta

Volumn 380, Issue 1-2, 2007, Pages 59-67

  Qin, Qiu Ping ^a   Wittfooth, Saara ^b   Pettersson, Kim ^b  

^a Innotrac Diagnostics Oy   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

ACS; Diagnosis; Immunoassay; PAPP A; Risk stratification

Indexed keywords

BIOLOGICAL MARKER; MAJOR BASIC PROTEIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A; TROPONIN;

ACUTE CORONARY SYNDROME; ANTIBODY SPECIFICITY; ATHEROSCLEROTIC PLAQUE; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CORONARY ARTERY ATHEROSCLEROSIS; DIAGNOSTIC VALUE; HEART DISEASE; HIGH RISK POPULATION; HUMAN; IMMUNOASSAY; MEDLINE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN STRUCTURE; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; STANDARDIZATION; THROMBOGENESIS;

ACUTE DISEASE; CORONARY DISEASE; FEMALE; HUMANS; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; SYNDROME;

ANGINA;

EID: 33947657288     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.02.036     Document Type: Review

References (59)

1. Myerburg RJ, Interian A Jr., Mitrani RM, Kessler KM, Castellanos A (Review). Frequency of sudden cardiac death and profiles of risk. Am J Cardiol 1997;80:10F-19F.
2. Pope J.H., Aufderheide T.P., Ruthazer R., et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med 342 (2000) 1163-1170
3. Lee T.H., Rouan G.W., Weisberg M.C., et al. Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room. Am J Cardiol 60 (1987) 219-224
4. White H.D. Newer antiplatelet agents in acute coronary syndromes (Review). Am Heart J 138 (1999) S570-S576
5. Apple FS, Wu AH, Mair J, et al. (Review). Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 2005;51:810-24.
6. Wu A.H. Markers for early detection of cardiac diseases (Review). Scand J Clin Lab Invest Suppl 240 (2005) 112-121
7. Bayes-Genis A., Conover C.A., Overgaard M.T., et al. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 345 (2001) 1022-1029
8. Qin Q.P., Kokkala S., Lund J., et al. Immunoassays developed for pregnancy-associated plasma protein-A (PAPP-A) in pregnancy may not recognize PAPP-A in acute coronary syndromes. Clin Chem 52 (2006) 398-404
9. Fredericks S., Bertomeu-Gonzalez V., Petrovic I., Holt D.W., and Kaski J.C. Comment on immunoassays developed for pregnancy-associated plasma protein-A (PAPP-A) in pregnancy may not recognize PAPP-A in acute coronary syndromes. Clin Chem 52 (2006) 1619-1620
10. Kaski J.C., and Holt D.W. Pregnancy-associated plasma protein-A and cardiovascular risk (Editorial). Eur Heart J 27 (2006) 1637-1639
11. Lawrence J.B., Oxvig C., Overgaard M.T., et al. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci U S A 96 (1999) 3149-3153
12. Laursen L.S., Overgaard M.T., Soe R., et al. Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A. FEBS Lett 504 (2001) 36-40
13. Bunn R.C., and Fowlkes J.L. Insulin-like growth factor binding protein proteolysis (Review). Trends Endocrinol Metab 14 (2003) 176-181
14. Conover C.A., Bale L.K., Overgaard M.T., et al. Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development. Development 131 (2004) 1187-1194
15. Qin X., Wergedal J.E., Rehage M., et al. Pregnancy-associated plasma protein (PAPP)-A increases osteoblast proliferation in vitro and bone formation in vivo. Endocrinology 147 (2006) 5653-5661
16. Kristensen T., Oxvig C., Sand O., Moller N.P., and Sottrup-Jensen L. Amino acid sequence of human pregnancy-associated plasma protein-A derived from cloned cDNA. Biochemistry 33 (1994) 1592-1598
17. Boldt H.B., Kjaer-Sorensen K., Overgaard M.T., et al. The Lin12-notch repeats of pregnancy-associated plasma protein-A bind calcium and determine its proteolytic specificity. J Biol Chem 279 (2004) 38525-38531
18. Bonno M., Oxvig C., Kephart G.M., et al. Localization of pregnancy-associated plasma protein-A and colocalization of pregnancy-associated plasma protein-A messenger ribonucleic acid and eosinophil granule major basic protein messenger ribonucleic acid in placenta. Lab Invest 71 (1994) 560-566
19. Wapner R., Thom E., Simpson J.L., et al. First-trimester screening for trisomies 21 and 18. N Engl J Med 349 (2003) 1405-1413
20. Oxvig C., Sand O., Kristensen T., Gleich G.J., and Sottrup-Jensen L. Circulating human pregnancy-associated plasma protein-A is disulfide-bridged to the proform of eosinophil major basic protein. J Biol Chem 268 (1993) 12243-12246
21. Qin Q.P., Christiansen M., Oxvig C., et al. Double-monoclonal immunofluorometric assays for pregnancy-associated plasma protein A/proeosinophil major basic protein (PAPP-A/proMBP) complex in first-trimester maternal serum screening for Down syndrome. Clin Chem 43 (1997) 2323-2332
22. Khosravi J., Diamandi A., Krishna R.G., Bodani U., Mistry J., and Khaja N. Pregnancy associated plasma protein-A: ultrasensitive immunoassay and determination in coronary heart disease. Clin Biochem 35 (2002) 531-538
23. Wittfooth S., Qin Q.P., Lund J., Tierala I., Takalo H., and Pettersson K. Immunofluorometric point-of-care assays for the detection of ACS related non-complexed PAPP-A. Clin Chem 52 (2006) 1794-1801
24. Overgaard M.T., Oxvig C., Christiansen M., et al. Messenger ribonucleic acid levels of pregnancy-associated plasma protein-A and the proform of eosinophil major basic protein: expression in human reproductive and nonreproductive tissues. Biol Reprod 61 (1999) 1083-1089
25. Qin Q.P., Kokkala S., Lund J., Tamm N., Voipio-Pulkki L.M., and Pettersson K. Molecular distinction of circulating pregnancy-associated plasma protein A in myocardial infarction and pregnancy. Clin Chem 51 (2005) 75-83
26. Sangiorgi G., Mauriello A., Bonanno E., et al. Pregnancy-associated plasma protein-a is markedly expressed by monocyte-macrophage cells in vulnerable and ruptured carotid atherosclerotic plaques: a link between inflammation and cerebrovascular events. J Am Coll Cardiol 47 (2006) 2201-2211
27. Bayes-Genis A., Schwartz R.S., Lewis D.A., et al. Insulin-like growth factor binding protein-4 protease produced by smooth muscle cells increases in the coronary artery after angioplasty. Arterioscler Thromb Vasc Biol 21 (2001) 335-341
28. Conover C., Harrington S.C., Bale L.K., and Oxvig C. Surface association of pregnancy associated plasma protein-A accounts for its co-localization with activated macrophages. Am J Physiol Heart Circ Physiol (Oct 13 2006) [Electronic publication ahead of print]
29. Lund J., Qin Q.P., Ilva T., et al. Pregnancy associated plasma protein A: a biomarker in acute ST-elevation myocardial infarction (STEMI). Ann Med 38 (2006) 221-228
30. Sivanandam A.S., Mohan S., Kapur S., et al. Covalent interaction between proform of eosinophil major basic protein (proMBP) and pregnancy-associated plasma protein-A (PAPP-A) is a cell-mediated event and required for proMBP inhibition of the catalytic activity of PAPP-A. Arch Biochem Biophys 423 (2004) 343-350
31. Overgaard M.T., Haaning J., Boldt H.B., et al. Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor. J Biol Chem 275 (2000) 31128-31133
32. Glerup S., Boldt H.B., Overgaard M.T., Sottrup-Jensen L., Giudice L.C., and Oxvig C. Proteinase inhibition by proform of eosinophil major basic protein (pro-MBP) is a multistep process of intra- and intermolecular disulfide rearrangements. J Biol Chem 280 (2005) 9823-9832
33. Stocker R., and Keaney Jr. J.F. New insights on oxidative stress in the artery wall (Review). J Thromb Haemost 3 (2005) 1825-1834
34. Cosin-Sales J., Christiansen M., Kaminski P., et al. Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. Circulation 109 (2004) 1724-1728
35. Beaudeux J.L., Burc L., Imbert-Bismut F., et al. Serum plasma pregnancy-associated protein A: a potential marker of echogenic carotid atherosclerotic plaques in asymptomatic hyperlipidemic subjects at high cardiovascular risk. Arterioscler Thromb Vasc Biol 23 (2003) e7-e10
36. Heeschen C., Dimmeler S., Hamm C.W., Fichtlscherer S., Simoons M.L., and Zeiher A.M. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol 45 (2005) 229-237
37. Lund J., Qin Q.P., Ilva T., et al. Circulating pregnancy-associated plasma protein a predicts outcome in patients with acute coronary syndrome but no troponin I elevation. Circulation 108 (2003) 1924-1926
38. Cosin-Sales J., Kaski J.C., Christiansen M., et al. Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris. Eur Heart J 26 (2005) 2093-2098
39. Elesber A.A., Conover C.A., Denktas A.E., et al. Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina. Eur Heart J 27 (2006) 1678-1684
40. Crea F., and Andreotti F. Pregnancy associated plasma protein-A and coronary atherosclerosis: marker, friend, or foe (Editorial)?. Eur Heart J 26 (2005) 2075-2076
41. Conti E., Carrozza C., Capoluongo E., et al. Insulin-like growth factor-1 as a vascular protective factor (Review). Circulation 110 (2004) 2260-2265
42. Libby P, Theroux P. (Review). Pathophysiology of coronary artery disease. Circulation. 2005;111:3481-8.
43. Dominguez-Rodriguez A., Abreu-Gonzalez P., Garcia-Gonzalez M., Ferrer J., and Vargas M. Circulating pregnancy-associated plasma protein A is not an early marker of acute myocardial infarction. Clin Biochem 38 (2005) 180-182
44. Qin Q.P., Laitinen P., Majamaa-Voltti K., Eriksson S., Kumpula E.K., and Pettersson K. Release patterns of pregnancy associated plasma protein A (PAPP-A) in patients with acute coronary syndromes. Scand Cardiovasc J 36 (2002) 358-361
45. Brugger-Andersen T., Hetland O., Ponitz V., Grundt H., and Nilsen D.W. The effect of primary percutaneous coronary intervention as compared to tenecteplase on myeloperoxidase, pregnancy-associated plasma protein A, soluble fibrin and D-dimer in acute myocardial infarction. Thromb Res 119 (2007) 415-421
46. Gluckman T.J., Sachdev M., Schulman S.P., and Blumenthal R.S. A simplified approach to the management of non-ST-segment elevation acute coronary syndromes (Review). JAMA 293 (2005) 349-357
47. O'Donoghue M., and Sabatine M.S. Appropriate invasive and conservative treatment approaches for patients with ST-elevation MI. Curr Treat Options Cardiovasc Med 8 (2006) 3-11
48. Laterza O.F., Cameron S.J., Chappell D., Sokoll L.J., and Green G.B. Evaluation of pregnancy-associated plasma protein A as a prognostic indicator in acute coronary syndrome patients. Clin Chim Acta 348 (2004) 163-169
49. Elesber A.A., Lerman A., Denktas A.E., et al. Pregnancy associated plasma protein-A and risk stratification of patients presenting with chest pain in the emergency department. Int J Cardiol (Jul 18 2006) [Electronic publication ahead of print]
50. Nyborg J.K., and Peersen O.B. That zincing feeling: the effects of EDTA on the behaviour of zinc-binding transcriptional regulators (Editorial). Biochem J 381 (2004) e3-e4
51. Qin Q.P., Christiansen M., and Pettersson K. Point-of-care time-resolved immunofluorometric assay for human pregnancy associated plasma protein A (PAPP-A) for use in first-trimester screening for Down syndrome. Clin Chem 48 (2002) 473-483
52. Spencer K. The influence of different sample collection types on the levels of markers used for Down's syndrome screening as measured by the Kryptor Immunosassay system. Ann Clin Biochem 40 (2003) 166-168
53. Sinosich M.J., Teisner B., Davey M., and Grudzinskas J.G. Pregnancy associated plasma protein-A: interaction with heparin in crossed affinity immunoelectrophoresis. Aust N Z J Med 11 (1981) 429-433
54. Weyer K., Overgaard M.T., Laursen L.S., et al. Cell surface adhesion of pregnancy-associated plasma protein-A is mediated by four clusters of basic residues located in its third and fourth CCP module. Eur J Biochem 271 (2004) 1525-1535
55. Toop K.M., and Klopper A. Effect of anticoagulants on the measurement of pregnancy-associated plasma protein-A (PAPP-A). Br J Obstet Gynaecol 90 (1983) 150-155
56. Overgaard M.T., Sorensen E.S., Stachowiak D., et al. Complex of pregnancy-associated plasma protein-A and the proform of eosinophil major basic protein. Disulfide structure and carbohydrate attachment. J Biol Chem 278 (2003) 2106-2117
57. Bersinger N.A., Meisser A., Bessou T., Seguin P., Birkhauser M.H., and Bischof P. Production and characterization of monoclonal antibodies against pregnancy-associated plasma protein A. Mol Hum Reprod 5 (1999) 675-681
58. Qin QP. Maternal serum screening for Down syndrome in the first trimester with special emphasis on pregnancy associated plasma protein A [PhD thesis]. Turku, Finland: University of Turku, 1998: 144 pp.
59. Bohn H., Chard T., Grudzinskas J.G., et al. Reference preparation for assay of some pregnancy and cancer associated proteins. Lancet ii (1980) 796